PRKAA2 and breast cancer: AMPK activation has also been reported to induce p53-dependent apoptotic effects in breast cancer cells (9),and inhibit the metastatic potential of melanoma cells by modulating the ERK signaling pathway and reducing the levels of the COX-2 protein (54).